RARB and lung cancer: However, the authors underlined that both ATRA resistance and hypoacetylation were attributable to methylated CpG islands adjacent to RARE in the RARβ promoter, in some cell lines but not in others, suggesting that multiple mechanisms contribute to this transcriptional defect in lung cancer cells [168].